After-hours movers: Zoom, Hims & Hers Health, Tempus AI, and more
After-hours movers:
Zoom (NASDAQ: ZM) fell 2% after guidance missed estimates. Zoom sees Q1 2026 revenue of $1.162-1.167 billion, versus the consensus of $1.175 billion.
Hims & Hers Health (NYSE: HIMS) fell 16% despite results that showed strong growth, after EPS missed estimates and management said they will pull commercial doses of its copycat of Ozempic. Revenue guidance topped views.
Tempus AI (NASDAQ: TEM) fell 9% despite year-over-year revenue growth of 35.8%. Tempus now expects full year 2025 revenue of approximately $1.24 billion for the consolidated Tempus and Ambry Genetics business, which represents approximately 79% annual growth, and Adjusted EBITDA of $5 million for full year 2025, an improvement of approximately $110 million over 2024.
Topgolf Callaway Brands (NYSE: MODG) rose 3% after it reported a narrow loss per share in the fourth quarter, despite guidance that missed consensus. Shares initially dropped 9% but quickly recovered.
EverQuote (NASDAQ: EVER) rose 28% after beating estimates on the top and bottom line.
Trex (NYSE: TREX) rose 3% after better than expected revenue and EPS. Fourth quarter 2024 net sales were $168 million, a decrease of 14.4% compared to $196 million reported in the prior-year quarter, impacted by a reduction in channel inventory of approximately $45 million. Gross profit was $55 million and gross margin was 32.7%.
Cleveland-Cliffs (NYSE: CLF) fell 2.5% after it reported results that trailed estimates. Fourth-quarter 2024 consolidated revenues were $4.3 billion, compared to prior-year fourth-quarter consolidated revenues of $5.1 billion.